The Journal of Immunology, Vol 146, Issue 7 2130-2136, Copyright © 1991 by American Association of Immunologists

ARTICLES

Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production

DW Pascual, JC Xu-Amano, H Kiyono, JR McGhee and KL Bost
Department of Microbiology, University of Alabama, Birmingham 35294.

The IgA producing murine B lymphoma, CH12.LX.C4.4F10 (4F10) and the IgM producing murine lymphoma, CH12.LX.C4.5F5 (5F5) were found to express substantial numbers of substance P (SP) receptors having dissociation constants equal to 0.69 nM. Binding of SP by these B lymphoma cells was via the tachykinin-specific C-terminus sequence, Phe-X-Gly-Leu-Met-NH2, because SP, SP antagonist (D-Pro2-D-Phe7-D-Trp9-SP), eledoisin, and substance K could effectively inhibit radiolabeled SP binding, whereas the SP N-terminus fragment, SP (1-4), could not. The functionality of these receptors could be demonstrated by the ability of subnanomolar concentrations of SP to induce Ig secretion in a dose-dependent fashion. However, the presence of a second stimulus in these cultures was required to obtain maximal increases. IgA secretion by 4F10 cells was elevated only 25 to 37%, and IgM secretion by 5F5 cells was not significantly increased in cultures in which nanomolar concentrations of SP were present. Conversely, coculturing 5F5 cells with a suboptimal concentration of LPS (50 ng/ml) and 10(-10)M SP resulted in an approximate threefold increase in supernatant IgM when compared to control cultures stimulated with LPS alone. While not as dramatic, 10(- 10) M SP also enhanced IgA secretion of LPS-stimulated 4F10 cells by approximately 45%. This enhancement of Ig secretion was SP-specific, as evidenced by the ability of 1000-fold excess of SP antagonist to block SP-induced, but not LPS-induced, Ig production. Clearly, SP could act synergistically with LPS to enhance Ig secretion; therefore, we questioned whether this augmentation was also reflected at the level of H chain mRNA expression. 10(-9)M SP induced modest increases (50 to 60%) in mu-chain mRNA expression by LPS-stimulated 5F5 cells when compared with cells stimulated with LPS alone. The 4F10 cells did not display this magnitude of difference for alpha-chain mRNA expression. Thus, although SP-induced increases of mu-chain mRNA by 5F5 cells may contribute to the increased Ig secretion observed by these LPS- activated lymphocytes, it is unlikely that increased mRNA expression can totally account for the threefold increases in secretion that were observed.

This article has been cited by other articles:

				S. W. Ng, H. Zhang, A. Hegde, and M. Bhatia Role of preprotachykinin-A gene products on multiple organ injury in LPS-induced endotoxemia J. Leukoc. Biol., February 1, 2008; 83(2): 288 - 295. [Abstract] [Full Text] [PDF]

				N. Walters, T. Trunkle, M. Sura, and D. W. Pascual Enhanced Immunoglobulin A Response and Protection against Salmonella enterica Serovar Typhimurium in the Absence of the Substance P Receptor Infect. Immun., January 1, 2005; 73(1): 317 - 324. [Abstract] [Full Text] [PDF]

				P. M. Glee, S. H. Pincus, D. K. McNamer, M. J. Smith, J. B. Burritt, and J. E. Cutler Peptide Ligands That Bind IgM Antibodies and Block Interaction with Antigen J. Immunol., July 15, 1999; 163(2): 826 - 833. [Abstract] [Full Text] [PDF]

				A. M. Blum, D. E. Elliott, A. Metwali, J. Li, K. Qadir, and J. V. Weinstock Substance P Regulates Somatostatin Expression in Inflammation J. Immunol., December 1, 1998; 161(11): 6316 - 6322. [Abstract] [Full Text] [PDF]

				T. Goode, J. O'Connell, C. Sternini, P. Anton, H. Wong, G. C. O'Sullivan, J. K. Collins, and F. Shanahan Substance P (Neurokinin-1) Receptor Is a Marker of Human Mucosal But Not Peripheral Mononulear Cells: Molecular Quantitation and Localization J. Immunol., September 1, 1998; 161(5): 2232 - 2240. [Abstract] [Full Text] [PDF]

				J. C. Reubi, U. Horisberger, A. Kappeler, and J. A. Laissue Localization of Receptors for Vasoactive Intestinal Peptide, Somatostatin, and Substance P in Distinct Compartments of Human Lymphoid Organs Blood, July 1, 1998; 92(1): 191 - 197. [Abstract] [Full Text] [PDF]